Why Corporate Social Responsibility Makes Sense
CSR is in the best interest of the public at large...and the pharmaceutical company itself.
Challenging Times for Noncommercial Researchers
New EU legislation heralds a difficult funding environment for nonprofit research centers.
A Consensus for Accreditation
A growing number of sponsors and regulators are recognizing that accredited organizations are more likely to be compliant.
Composite Endpoints: Proceed with Caution
The use of composite endpoints are being regarded as a useful strategy, but caution must be applied as there are both risks and benefits.
Another Step Toward EU Pediatric Trials
EU Council supports pediatric medicines proposal, but adds some changes.
eShowcase
Tools for Clinical Trials Professionals
FDA Outlines Critical Path Opportunities
The much anticipated list features initiatives in biomarkers and research productivity.
